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Abstract
Documenting genome diversity is important for the local biomedical communities and instrumental in developing precision and
personalized medicine. Currently, tens of thousands of whole-genome sequences from Europe are publicly available, but most of
these represent populations of developed countries of Europe. The uneven distribution of the available data is further impaired by
the lack of data sharing. Recent whole-genome studies in Eastern Europe, one in Ukraine and one in Russia, demonstrated that local
genome diversity and population structure from Eastern Europe historically had not been fully represented. An unexpected wealth of
genomic variation uncovered in these studies was not so much a consequence of high variation within their population, but rather
due to the “pioneer advantage.” We discovered more variants because we were the first to prospect in the Eastern European genome
pool. This simple comparison underscores the importance of removing the remaining geographic genome deserts from the rest of
the world map of the human genome diversity.
Keywords: genomes, Europe, Ukraine, Russia, genome diversity, whole-genome sequencing, variants, genome project, genotyping,
genome deserts

It has been more than two decades since data of the first human genome project (HGP) were publicly released [1, 2], leading
to a revolution in biomedical research. Evaluating torrents of data
coming from sequencing enabled a genomic-based approach to
study human health, disease, and natural history in an evolutionary context. After the HGP established the baseline for understanding common genetic variation, the analysis of genomic diversity discovered from comparing genomes of different species,
multiple individuals, and across diverse populations worldwide
led to the effective annotation of clinically relevant variants essential in understanding disease origin, health risks, drug sensitivity, and the promise and the perspectives of personalized
medicine.
At this first stage of mapping global genome diversity, efforts
were led by the global consortia of scientists who collaborated to
discover and classify genome variation across the globe: Human
Genome Diversity Panel (HGDP) and the 1,000 Genomes (G1K)
project [3, 4] represented a monumental effort of the international community that focused on creating a comprehensive genetic diversity map of humankind. However, after the initial success, this concerted effort seems to have dissipated, leaving many
blank spots, missing many local and rare variants critically important for characterization of human diversity. In the second
stage of mapping worldwide genome diversity, national projects
replaced the global surveys to serve as a major reference resource
for human genetic variation and to provide locally based annotation of disease variants. National genome projects were supported by country governments [5, 6], international collaborations

[7], and/or groups of enthusiasts [8]. These efforts continued to
contribute, without the unified systematic global strategy. The
projects provide an unequal geographic and population coverage
and thus a fractured picture of the genome diversity across the
continents.
Geographic genome surveys across populations supported the
earlier conclusions of population structure, when in the 1990s,
Luca Cavalli-Sforza identified 5 major clinal patterns throughout
Europe [9]. While the exact distribution of these clines continues
to be debated and redrawn, the population genetic structure of Europe is undoubtedly real, and similar patterns have continued to
be found in more recent studies. Increasing numbers of autosomal
single-nucleotide polymorphisms (SNPs; from 9,000 to 300,000) affirmed strong continent-wide correlation between geography and
genetic distance [10–12]. Early surveys did not include Northeastern and Eastern Europe. Then, studies from Finland, Estonia, and
the Komi Republic (Russia) showed distinct genetic diversity in
Northeastern Europe, associated with the Uralic language family [13, 14]. This analysis of the European population eventually
displayed a phylogeographic patterning, further underscoring the
importance of local genome variation for biomedical studies [12,
15].
As of July 2022 at least 3,089 whole-genome sequences from
different continental European populations have become publicly
available in addition to the 2,638 genomes sequenced and publicly
released by the research groups in Iceland [16] and 204,109 in the
United Kingdom [17] (Fig. 1; Table 1; Supplementary Table S1). The
distribution of the available genomes is still partially explained by
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the initial efforts by the HGDP and the G1K projects [3, 4], but a
quick look at the map of Europe is enough to see that most of the
data in these genome projects, as in the genotyping projects before, represent the populations of the United Kingdom and technologically advanced countries of the European Union (Fig. 1),
while the diversity within many countries in Eastern Europe is
represented by a handful of genomes each. The HGDP and the G1K
projects followed sampling schemes that were biased by the geographic composition of the consortia and sample availability and
left many important regions of genetic diversity unexplored [18].
Some of these regions will be eventually addressed by the Genome
of Europe initiative that aims to build a European network of national genomic reference cohorts of at least 500,000 European citizens selected to be representative of the European population [16].
This ambitious and worthwhile goal is welcome but has not yet
been released in 2022. Other projects like the Personal Genome
Project may also be useful given that they carry geographical context [19]. However, as genome sequencing shifted from the international consortia to the national projects, the intrinsic bias in
the distribution of human genome data available from Europe remained [20]. Table 1 incorporates the current status of the geographically referenced whole-genome data in Europe.
Multiple types of efforts to aggregate current known variation
are under way. To cover the highest number of samples and include projects with varying data release strategies, first the Exome Aggregation Consortium (ExAC) and then the Genome Aggregation Database (gnomAD) omitted the individual-level information. Today, gnomAD has provided publicly available and accessible variation summaries from as many as 76,156 individual genomes of various projects across the globe [21, 22]. These
datasets are easy to handle and to interpret and can be useful

for comparative analysis and identification of novel variation, but
they are not well suited for population analysis on the smaller
scale. On the other hand, the Database of Genotypes and Phenotypes provides resources like the individual variants and an extensive amount of phenotypical information per sample but requires additional bioinformatic expertise to handle [23]. Often,
the nature of these data means that data access is controlled
and requires an application with appropriate justification. To ensure data security, specialized instruments and tokens are often
needed to reach the data. These necessary precautions can create
delays or outright limit a research group in its ability to reach the
data, given a lack of technical expertise.
Recently, analysis of the data from whole-genome studies,
one in Ukraine [8] and one in Russia [24], clearly demonstrated
that intrinsic genomic diversity from Eastern Europe had been
poorly represented. The SNP allele frequency differences are large
enough to provide previously unknown dimensions of population
structure. For instance, Zhernakova et al. [24] identified 5 distinct
phylogeographic population partitions from east to west across
the 11 time zones of the Russian Federation. They also reported
important genetic differences between ethnic Russian populations and their neighbors. The principal component analysis of
Russian subpopulations from Pskov and Novgorod in the European part of Russia compared with other populations of Europe
and Asia (264 study participants) demonstrated genetic distinctiveness as great or greater than differences between populations
of neighboring Finns, Swedes, and Estonians [24]. A subsequent
analysis of Ukrainian genomes showed that the Ukrainian cluster
was distinct from publicly available European populations or publicly available genomes from subpopulations of ethnic Russians in
the European part of Russia [3, 8].
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Figure 1. Public availability of whole-genome sequences in Europe. Numbers that represent total sample sizes for each country, geographic
subpopulations, and ethnic minorities and numbers of individuals for each subpopulation/study are shown in Table 1. Links to the open data for each
study summarized in this table are provided in Supplementary Table S1.
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Total # samples per
country

#
Populations/studies
per country

Albania

4

2

Azerbaijan

2

1

Belarus

4

1

Bosnia-Herzegovina

7

2

Country (population)

Bulgaria

2

1

Czechia

1

1

150

1

Estonia

8

2

Finland

113

4

France

51

4

Denmark

Georgia

Germany
Greece

Hungary
Iceland
Italy

9

3

1

254

3

3

2

2,638

2

159

7

3

1

Lithuania

4

2

Moldova

2

1

769

1

4

2

Norway

# Subpopulations/
studies

# Samples per
subpopulation/study

Albanians

2

4

Azeri

1

2

Belarusians

1

4

Croats
Roma

1
1

4
3

Bulgarians

1

2

Czechi

1

1

Danes

1

150

Estonians

2

8

Finnish

4

113

Basques
French

2
2

24
27

Abkhazians
Georgians

2
2

5
4

Germans

1

3

Cretans
Mainland Greeks

2
1

252
2

Hungarians

2

3

Icelanders

2

2,638

Italians
Sardinians

5
2

132
27

Latvians

1

3

Lithuanians

2

4

Moldovans

1

2

Dutch

1

769

Finnish
Norwegians

1
1

3
1

Orcadians

2

15

Poles

2

5

Adygeis
Avars
Azerbaijanis
Balkars

2
1
1
1

17
3
1
3

4

Latvia

Netherlands

Population or
subpopulation names

Orkney Islands

15

2

Poland

5

2

Russia∗

178

34
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Table 1. Sequences of individual genomes available in Europe. The datasets are classified by source countries, and the total number
of samples per country is given. Within each country, genomes may be derived from several independent studies that represent the
population of the country, geographic subpopulations, and ethnic minorities, and numbers of individuals for each subpopulation/study
are listed in the last column. Links to the open data for each study summarized in this table, including references, databases, and links
to the studies, are provided in Supplementary Table S1. Ethnic populations and subpopulations within each country are shown in italics.
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Table 1. (Continued)

Spain

#
Populations/studies
per country

164

2

Sweden

1,002

2

Turkey

2

1

Ukraine

257

7

United Kingdom

Total

204,109

9,917

Population or
subpopulation names

# Subpopulations/
studies

# Samples per
subpopulation/study

Bashkirs
Chechen
Circassians
Ingrians
Kabardins
Karelians
Khantys
Komis
Kryashen-Tatars
Kuban-Cossacks
Kumyks
Lezgins
Mansis
Maris
Mishar-Tatars
Mordvins
North-Ossetians
Russians∗
Tabasarans
Vepsas

1
1
1
1
1
1
1
1
1
1
1
2
2
1
1
1
2
7
1
1

5
1
3
3
4
3
3
2
3
2
3
6
5
4
1
3
4
92
3
4

Spanish

2

164

Swedes

2

1,002

Turks

2

1

Cossacks
Hungarians
Ukrainians

1
1
5

2
1
254

British
English

3
1

204,107
2
209,836

3

96

∗Only the populations native to the European part of the Russian Federation are represented in this survey.

These 2 studies discovered millions of mutations, many of
which were previously not described (478,000 in Ukraine [8] and
approximately 300,000 in 2 populations from the European Russia
[24]) and reported major differences in frequencies of medically
related alleles between Eastern Europe and the rest of the continent. This wealth of genomic variation uncovered in Ukraine and,
to the lesser extent, in Russia was not due to the particularly high
variation within the Ukrainian population but to the absence of
sampling variation from the countries around Ukraine.
The effect observed is due to what is known in the business and
marketing world as a “first-mover” or “pioneer advantage” [25].
Since the Ukrainian population was surrounded by unexplored
genome deserts, the study of fewer than 100 Ukrainian genomes
uncovered 478,000 novel genomic SNPs that have never been previously registered in the Genome Aggregation Database [26]. This
number is huge, even in comparison to the most genetically diverse populations in sub-Saharan Africa, where the addition of
new genomes from 426 people across 50 ethnolinguistic groups
to the existing databases revealed approximately 3 million variants [27]. This simple comparison underscores the importance of

complete information about the global extent of genome variation and removing remaining genome deserts from the rest of the
world map.
Understanding all geographic dimensions of genome diversity
in Europe is crucial for the local biomedical community to use local genomics data instead of extrapolating results from genome
projects in other countries. The importance of sequence data
from multiple populations cannot be underestimated, given their
unique histories of drift, selection, migration, admixture, and socioeconomic structures. Therefore, we suggest that every country needs its own national genome database to inform regionally
relevant and objective public health policies. There is still a lot
of important variation to be discovered, and it needs to be made
public to provide the informational framework for the biomedical
research to follow.
Currently, the largest genome representation in Europe is in
the United Kingdom [5] due to a well-funded national project, including more that 200,000 genomes publicly available for analysis. Countries like Iceland (2,638), the Netherlands (769), Italy
(159), Spain (164), and Sweden (1,002) also shared large se-
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annotation and other genome features, so that these could join
other international genome sequence consortia releasers [6, 8, 18,
24]. The design and even the informed consent protocols for both
of these projects were actually modeled after the 1,000 Genomes
Project, which had been vetted by the world’s experts on human
genome ethics. The original intention and promise was to join
and augment the catalogue of genomes in the 1,000 Genomes
Project as well as the SNP annotations to complement ExAc [22],
gnomAd [21], Gene Mutation Database (HGMD), and HGMD-DM
(disease-causing mutations) [31]. The political shuttering of open
release by Russian authorities would ultimately cost all these
important projects until release was remedied. This ill-advised
suspension of open release was further exacerbated by the 2022
February 24 invasion of Ukraine ordered by Russian President
Putin.
Researchers can still retrieve ethnic Russian genomes scattered in small batches across other publications, as well as
from modest representation of multiple non-Russian ethnic
minorities who make up almost half of the genomes still
available from the European part of the Russian Federation.
From the European part of Russia, genomes from 23 ethnically distinct indigenous populations are available, such as
Ossetians, Tatars, Chechens, Komis, Bashkirs, Mordvins, and
others, in addition to 7 subpopulations of ethnic Russians
(Table 1).
The uneven distribution of the genome data in Europe is further exacerbated by widespread lack of data sharing in the scientific community. While commercial companies are compiling but
restricting massive data among themselves, the genome-wide sequence data from ancestry testing and diagnostic sequencing [32]
are difficult or impossible to retrieve [24, 33]. This is usually justified by the possibility that, even when the databases are completely anonymous, it is technically possible to identify participating individuals with additional genotype information [34]. Therefore, publishing individual genome data needs appropriate levels
of informed consent that require a combination of technical and
societal stipulations within the context in which the data are released. There remains a stunning lack of consensus or compelling
legal precedents involving ownership or open release of biomedical materials and derivative data [35]. Different published studies (genomes, GWAS (Genome Wide association Study), and others) have been collected under widely diverse levels of informed
consent agreed on by the study participants. All this ambiguity
compels many in management/privacy positions to simply deny
access to both samples and data, a serious problem that may be
getting worse.
We emphasize the importance of public access to the data
that is consented and open. The best practice, pioneered by
the G1K consortium, was to deposit the collected genome sequences, informed consent details, and the accompanying data
into an international database that could serve as a valuable
resource for the researchers worldwide, while providing security and protecting the interests of participating individuals and
the communities they represent [4]. Publicly available genome
data generated from the general population of the country
have a vital role to unlock the capacities of genomic-based
personal medicine for residents of a given county and benefit
everyone.

Abbreviations
ExAC: Exome Aggregation Consortium; G1K: 1,000 Genomes
Project; gnomAD: Genome Aggregation Database; HGDP: Human
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quence databases with the scientific community (Table 1). Still,
many countries in Europe remain underrepresented. Aside from
Belgium, Portugal, and Switzerland, most of these underrepresented countries are in Eastern Europe. Poland has recently
started its national genome project that will soon contribute
thousands of genomes to the public domain [28]. Austria, Croatia, Montenegro, North Macedonia, Romania, Serbia, and Slovakia have no representation in the public genome databases
yet, and several other countries such as Bosnia-Herzegovina, Bulgaria, Belarus, Czechia, Hungary, Lithuania, Latvia, and Moldova
have only a handful genomes included in international projects
[4, 7, 29].
Funding for the national genome projects has come from various sources and often combines private and public sources. Unfortunately, successful genomic initiatives rarely come from countries from smaller economies. Ukraine is an outlier in this category (an Eastern European country with a relatively small economy with 254 genomes available), due to a successful collaboration strategy. Lacking support of the Ukrainian government,
samples became available through international collaborations
with BGI (formerly the Beijing Genomics Institute) as well as
the National Institutes of Health (USA), specifically to help fill
in the genome desert in that country [8]. This approach can
be replicated if the principal roadblock to a national genome
project is the lack of local funding in countries with smaller
economies.
The national genomic projects offer an effective platform
for training genome scientists and bioinformaticians at the
national level. Research teams involved in national genomic
projects should be multidisciplinary and interinstitutional and
include policy makers, lawyers, data scientists, and human geneticists. There is a critical need for involving experts in the
humanities, especially those who understand relevant ethical
and social issues. Given this complexity, international collaborations can be very helpful and can be defined from the beginning of the project, not only for writing the collection protocols and providing sequencing platforms but also for serving the ultimate objectives—improving public health in each
country.
Politics matters in these efforts and not always for the good.
The Genome Russia project was conceived as a platform that
would bring together scientists from across the Russian Federation with international collaborations from across the globe (http:
//genomerussia.spbu.ru/) [6, 18]. The hope was that this project
would include a program to train bioinformatics experts who
could carry on the torch for the next generation of genome studies. After the initial success in building a consortium and a first
analysis/data publication [24], public access to the genome data
was initially approved by NCBI, then abruptly retracted by direct order of Russian authorities after the paper was published.
The 2022 hostilities in Ukraine from Russian invaders bode rather
poorly for immediate remedy of these issues. The publication
of Ukrainian genomes was met with hostility by the Russian
authorities, who demanded the retraction of the manuscript,
first the preprint from bioRxiv and then the paper from GigaScience [30]. Genome diversity of the Ukraine paper was ultimately published, and all the data (except the Genome Russia
genomes) were released publicly over the Russian objections and
presure.
As stipulated in the original proposal and development documents for the Genome Russia and cooperative agreements for
the Genome Diversity in Ukraine projects, the principal goal of
these efforts was to provide open access of all sequence data SNP
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Genome Diversity Panel; HGP: Human Genome Project; SNP:
single-nucleotide polymorphism.
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